2-(4-bromophenyl)-5,8-dioxaspiro[3.4]octane-2-carboxylic acid is employed as pharmaceutical intermeidate to prepare the inhibitors of AKT activity for cancer treatment.
Signal Word
Hazard Statements
Precautionary Statements
HS Code
RIDADR
Legal Information
Warning
H317,H319
P280, P305+P351+P338
NONH for all modes of transport
1. Product Specification
2. Safety Data Sheet
Please inquire for pricing and availability of this product by writing email tosales@kumidas.com.
